The chemotactic response of leukocytes is a behavioral phenomenon that is the end result of a complex series of integrated biochemical events. Chemotaxis appears to require recognition by cells of chemical gradients in their surrounding environment, transduction of this information from the exterior to the interior of the cell, and translation of the information into directed cell movement through alterations in cellular metabolism and rearrangement ofcytoskeletal elements (1-6). It has recently been established that leukocytes contain specific cell-surface receptors for certain chemoattractants and it has been surmised that these receptors are important in initiating the'biological effects of the chemotactic factors (1-3).
Inc., San Carlos, Calif. Noformyl-methionyl-methionyl-methionine (fMet-Met-Met) and Nformyl-methionyl-leucine (fMet-Leu) were ~urchased from Andrulis Research Corp., Bethesda, Md. Tritiated fMet-Leu-Phe (fMet-Leu-[ H]Phe) (57 Ci/mmoi) was from New England Nuclear, Boston, Mass., and Hepes was obtained from Calbiochem-Behring Corp., American Hoechst Corp., San Diego, Calif. Phenolphthalein glucuronic acid and dried Micrococcus lysodeikticus were purchased from Sigma Chemical Co., St. Louis, Mo. The chemotactic stimulants zymosan, activated human serum (14) , and lymphocyte-derived chemotactic factor (15, 16) were prepared as previously described.
Cell preparations. U937 cells were grown in RPMI-1640 medium that contained 10% (vol/ vol) heat-inactivated (30 min at 56"C) fetal calf serum (RPMI-FCS) (B & B Research Laboratories, Baltimore, Md.). The cells were maintained at 37"C and passaged as previously described (9) . Before use in the functional and binding assays, the cells were washed twice in phosphate-buffered saline that contained 1.7 mM KHzPO4, 8 mM NazHPO4, 0.117 M NaCI, 0.15 mM CaClz, and 0.5 mM MgCI2, pH 7.2 (incubation buffer).
Preparation ofLymphokine-ri'ch Supernates. Human mononuclear leukocytes obtained by separation of whole human blood on Fieoll-(Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.) Hypaque (Winthrop Laboratories, New York) gradients were incubated in RPMI-FCS for 48 h at 37°C in the presence of 1 btg/ml phytohemagglutinin (BurroughsWellcome Corp., Research Triangle Park, N. C.). After incubation, the cell supernates were collected after centrifugation and stored at -200C until used.
Chemotaxis Assay. Chemotaxis was assayed in modified Boyden chambers using a 5.0-#m polycarbonate filter (Nuclepore Corp., Pleasanton, Calif.) (15, 17) . Chemotactic activity of the various stimulants was measured as the mean number of migrating cells per oil-immersion microscopic field (magnification: X 1,000) in triplicate samples and is expressed as the percentage of the maximal response obtained with each chemoattractant.
fMet-Leu-[3H]
Phe-binding Assay. Five million U937 cells were incubated with the indicated concentration of fMet-Leu-[SH]Phe in a total voi of 0.15 ml in the presence and absence of 10 laM unlabeled fMet-Leu-Pbe. After the appropriate incubation time at 23°C, t;he cell suspensions were rapidly filtered onto glass fiber discs (Whatman GF/C; Whatman, Inc., Clifton, N. J.) (1), which were then washed with 24 ml of ice-cold incubation buffer. The filters were placed into scintillation vials with 10 ml of Aquasol (Imperial Chemical Industries, Inc., Los Angeles, Calif.) and the radioactivity was measured by liquid scintillation spectroscopy. Specific binding is defined as total binding minus nonspecific binding which is the amount of fMetLeu-[ H]Phe bound in the presence of 10 #M unlabeled fMet-Leu-Phe (18, 19) .
Assay of Lysosomal Enzyme
Release, U937 cells (5 × 10 n eells/ml) were suspended in phosphatebuffered saline that contained .138 M NaCI, 2.7 mM KCI, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, 0.6 mM CaCI~, and 1.0 mM MgCI2, pH 7.4 (20) in the presence and absence of 10 -s M cytochalasin B. After incubation for 15 min. at 37°C, ehemotactic factors or buffer alone were added to the cells and the reaction was allowed to proceed for 15 rain at 37°C. The tubes were then immersed in an ice bath and centrifuged. The supernates were assayed for lysozyme (21) ,/~-glucuronidase (22) , and lactic acid dehydrogenase (LDH) (23) .
Results

Kinetics of the Development of Chemotaxis and Lysosomal Enzyme Secretion in U937 Cells
Treated with Lymphokines. Our previous studies demonstrated that U937 cells, when incubated with lymphokines, developed a chemotactic response to fMet-Leu-Phe (11). To determine whether stimulated U937 cells developed another chemoattractantinduced function, lysosomal enzyme secretion (13) , the cells were incubated with RPMI-FCS that contained 5% (vol/vol) lymphokine supernates for 24, 48, or 72 h, washed, and tested for their ability to release B-glucuronidase and lysozyme in response to 10 btM fMet-Leu-Phe (Fig. 1 A) . These cells were also studied for chemotactic responsiveness to the same agent (Fig. 1 B) . Unactivated U937 cells released small but significant amounts of B-glucuronidase and lysozyme in the presence of peptide and 10 ~M cytochalasin B (Fig. 1A) . When the cells were stimulated with lymphokines, the release of both enzymes increased markedly with increased time of incubation. Maximal release of lysozyme occurred in cells that had been incubated for 48 h with lymphokines, and was 41% of the total lysozyme content, fl-glucuronidase release was maximal after 72 h, and was 42% of the total amount of this enzyme. The cellular content of both enzymes increased with increasing time of stimulation with lymphokines. Lysozyme content at 0, 24, 48, and 72 h after stimulation was 0.9 ± 0.1, 0.8 + 0.03, 1.3 + 0.1, and 1.6 4-0.06 ~g equivalent lysozyme units/106 cells, respectively, and values for total fl-glucuronidase content were 48.6 ± 1.3, 50.8 ± 0.9, 99.2 ± 7.2, 126.6 4-5.0/zmol phenolphthalein formed/h per 106 cells, respectively. The release of lysosomal enzymes in response to fMet-Leu-Phe was not a result of cell death because there was no observable release of the cytoplasmic enzyme, LDH. The appearance of lysosomal enzyme secretion in U937 cells paralleled the appearance of chemotactic responsiveness to 50 nM fMet-Leu-Phe ( Fig. 1 B) . 
Kinetics of the Appearance of fMet-Leu-[aH]Phe-binding Sites on U937 Cells after Activation
Kinetics and Reversibility of fMet-Leu-[3H]
Phe Binding to Activated U937 Cells. U937 cells that had been grown for 48 h in the presence of 5% (vol/vol) lymphokine-rich supernates were incubated with 10 nM fMet-Leu-[nH]Phe, and specific binding was assayed at various times after incubation at 23°C (Fig. 3) . The binding of fMet-Leu-[aH]Phe reached equilibrium by 45 min; the time required to reach one-half equilibration (tl/2) was ~ 16 min at 25°C. To determine whether the binding of fMet-Leu-[aH]Phe was reversible, a large excess (10 ~M) of unlabeled fMet-Leu-Phe was added to an equilibrated mixture of the labeled ligand and U937 cells, and specific binding was assayed after various times thereafter (Fig. 3) . The bound fMet-Leu-[nH]Phe was rapidly displaced by the addition of the unlabeled peptide; >50% of the bound peptide was displaced by 5 rain after the addition of unlabeled fMet-Leu-Phe. peptides. U937 cells were cultured for 48 h with lymphokines and tested for their ability to respond chemotactically to various concentrations of a series of N-formylated peptides. Fig. 4 indicates that the peptides, fMet-Leu-Phe, fNle-Leu-Phe, and fMetMet-Met were approximately equipotent for eliciting a chemotactic response in stimulated U937 cells, whereas the peptide fMet-Leu was less potent by approximately three orders of magnitude. These results are in good agreement with the potencies of these same peptides for producing a chemotactic response in guinea pig macrophages (25) .
Specificity of the N-Formylated
The same peptides were also tested for their relative potency for inducing lysosomal enzyme secretion by U937 cells. Cytochalasin B-treated cells, which had been stimulated with lymphokines for 48 h, were incubated with various concentrations of the peptides for 15 min at 37°C, after which time the amount of lysozyme and /~-glucuronidase activities in the supernate fluid was measured. The peptides exhibited the same order of potency for releasing lysozyme activity from the U937 cells (Fig. 5) as was noted for the induction of the chemotactic response, fMet-Leu-Phe -fNleLeu-Phe = fMet-Met-Met > fMet-Leu. Identical results were obtained when flglucuronidase activity was measured in the cell supernates. The concentrations of peptides necessary to induce lysosomal enzyme release were 10-15 times greater than the concentrations necessary for eliciting a chemotactic response, a phenomenon which has also been noted in studies using rabbit polymorphonuclear leukocytes (13) .
If (Fig. 6 ). The order of potencies of these peptides in competing for tMet-Leu-[aH]Phe-binding sites exactly paralleled their order of potencies for producing chemotactic responses and lysosomal enzyme release. Excellent correlation between the doses of peptides which produced one-half maximal inhibition of binding (EC~0) and half maximal lysosomai enzyme release (r = 0.99) and chemotaxis (r = 0.99) were obtained.
Discussion
The monocyte-like cell line U937, established from a human histiocytic lymphoma (7) was adapted to rapid growth in vitro (9) . U937 cells have low levels of antibodydependent cellular cytotoxicity, immune phagocytic activity, and Fc receptors in the unstimulated state, but develop increased killer and phagocytic activity as well as Fc receptors upon incubation with lymphokines (9) . Our studies demonstrate that other The affinity of a series of N-formylated peptides for the receptor on stimulated U937 cells paralleled the activity of the peptides for producing chemotaxis and lysosomal enzyme release, thereby demonstrating the specificity of the receptor as well as its biological relevance. The correlation coefficients (r) calculated from the ECs0 for inhibition of fMet-Leu-[3H]Phe binding and the ECs0 for chemotaxis and lysosomal enzyme secretion were both 0.99. The specificity of the receptor on activated U937 cells was similar to that found on guinea pig macrophages (25, 26) , but may be slightly different from that present on human peripheral blood monocytes. The potencies of fMet-Met-Met and fNle-Leu-Phe for human monocyte chemotaxis are less than that of fMet-Leu-Phe (M. C. Pike and R. Snyderman. Unpublished observation.), whereas the potencies of all three peptides for chemotaxis by stimulated U937 cells are identical. The affinity of fMet-Leu-Phe for the receptor on stimulated U937 cells (15-30 nM) is similar to the affinity of fMet-Leu-Phe for the receptors on guinea pig maerophages (8-12 nM) and human polymorphonuclear leukocytes (10-15 nM) (1) . The affinity of fMet-Leu-Phe for human monocytes has not yet been determined by direct binding assay.
The availability of a human monocyte-like cell line that, in one state, lacks detectable amounts of the N-formylated chemotactic peptide receptor, but possesses it in another state, will greatly facilitate both the biochemical characterization of the receptor and provide information concerning the regulation of the biological activities of leukocytes during differentiation processes. This cell line should also be useful for further delineating the transductional events that occur after receptor binding and that are required for chemotaxis and lysosomal enzyme release. Summary A human monocyte-like cell line, U937, when grown in continuous culture, does not secrete lysosomal enzymes or migrate towards chemotactic factors. When the cells are stimulated by lymphokines, however, they develop the ability both to migrate directionally and to secrete enzymes in response to several types of chemoattractants. The development, by stimulated cells, of chemotactic and secretory responses to one class of chemoattractants, the N-formylated peptides, is accompanied by the appearance on the cells of specific binding sites for these substances. Using tritiated Nformyl-methionyl-leueyl-phenylalanine (fMet-Leu-[nH]Phe) as a ligand, it was determined that unstimulated U937 cells possess no detectable binding sites. However, after stimulation with lymphocyte culture supernates for 24, 48, and 72 h, they developed 4,505 ± 1,138, 22,150 ± 4,030, and 37,200 :lz 8,000 sites/cell, respectively. The dissociation constants for the interaction of fMet-Leu-[SH]Phe with the binding sites were approximately the same regardless of stimulation time and ranged between 15 and 30 nM. The binding of fMet-Leu-[3H]Phe by stimulated U937 cells was rapid and readily reversed by the addition of a large excess of unlabeled peptide. The affinity of a series of N-formylated peptides for binding to U937 cells exactly reflected the potency of the peptides in inducing lysosomal enzyme secretion and chemotaxis. The availability of a continuous human monocytic cell line that can be induced to express receptors for N-formylated peptides will provide a useful tool not only for the characterization of such receptors but also for the delineation of regulatory mechanisms involved in cellular differentiation and the chemotactic response.
Received for publication 3 March 1980. 
